Company: DVAX
Filing Date: 2025-04-15
Form Type: PRER14A
Source: 0000930413-25-001254
Chunk: 38

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-04-15
Form: PRER14A
Chunk 38
---
 |     |              |     |         |     |        |     |        |     |           |     |          |     |            |     |        |     | 7 / 9 |
| Operational                     
 / Commercial Experience         |     |             |     |              |     |         |     |        |     |        |     |           |     |          |     |            |     |        |     | 9 / 9 |
| Clinical Development            |     |             |     |              |     |         |     |        |     |        |     |           |     |          |     |            |     |        |     | 5 / 9 |
| Business                        
 Development/M&A Experience      |     |             |     |              |     |         |     |        |     |        |     |           |     |          |     |            |     |        |     | 8 / 9 |
| Finance/Capital                 
 Allocation                      |     |             |     |              |     |         |     |        |     |        |     |           |     |          |     |            |     |        |     | 8 / 9 |
| Public                          
 Company C-Suite Experience      |     |             |     |              |     |         |     |        |     |        |     |           |     |          |     |            |     |        |     | 6 / 9 |
| Public                          
 Health/Government               |     |             |     |              |     |         |     |        |     |        |     |           |     |          |     |            |     |        |     | 2 / 9 |
| Other                           
 Public Company Board Experience |     |             |     |              |     |         |     |        |     |        |     |           |     |          |     |            |     |        |     | 6 / 9 |

| 27 |

INDEPENDENCE OF THE BOARD OF DIRECTORS

As required under the Nasdaq listing standards, and our Corporate Governance Guidelines, independent directors
must comprise a majority of our Board. Under Nasdaq rules, a director will only qualify as independent if the listed company’s
Board makes an affirmative determination that the person does not have a relationship that would interfere with the exercise of
independent judgment in carrying out the responsibilities of a director. In addition, applicable Nasdaq rules require that, subject
to specified exceptions